UMIN ID: UMIN000001170
Registered date:01/05/2014
Treatment efficacy of short-term PEG-IFN alpha for chronic hepatitis C patients with genotype 2 and low viral road
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | chronic hepatitis C |
Date of first enrollment | 2008/05/01 |
Target sample size | 220 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | a group of short-term PEG-IFN alpha therapy a group of ordinary-term PEG-IFN alpha therapy |
Outcome(s)
Primary Outcome | HCV-RNA |
---|---|
Secondary Outcome | transaminase |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 75years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | liver dysfunction with other causes Allergy to Interferon (IFN) during pregnancy Severe comlication-especially, poor hematopoiesis, renal, cardiac or respiratory function |
Related Information
Primary Sponsor | Gunma Liver Study Group |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Gunma Liver Study Group |
Secondary ID(s) |
Contact
public contact | |
Name | Ken Sato |
Address | 3-39-15 Showa, Maebashi, Gunma, 371-8511, Japan Japan |
Telephone | 027-220-8127 |
satoken@gunma-u.ac.jp | |
Affiliation | Gunma University Graduate School of Medicine Department of Medicine and Molecular Science |
scientific contact | |
Name | Ken Sato |
Address | 3-39-15 Showa, Maebashi, Gunma, 371-8511, Japan Japan |
Telephone | 027-220-8127 |
satoken@gunma-u.ac.jp | |
Affiliation | Gunma University Graduate School of Medicine Department of Medicine and Molecular Science |